Anti Angiogenic

Anti Angiogenic - most related articles:

- Thalidomide does not improve survival in lung cancer - 6.6
- Drugs for epilepsy increases fracture risk in older - 2.9
- Herpes zoster or shingles risk more with rheumatoid arthritis medicines - 2.8
- Anti inflammatory drugs reduce effectiveness of SSRI antidepressants - 2.5
- Controlling inflammation in macular degeneration prevents progress of AMD - 2.4
- Blood test can predict rheumatoid arthritis early - 2.3
- Tobacco companies challenged anti smoking signs in US - 2.3
- Down syndrome patients have a reduced risk for cancer - 2.2
- Novel anti malarial drug candidate found - 2.2
- Exercise gene could help with depression - 2.1

Anti Angiogenic articles

Shark cartilage drug AE-941 does not improve lung cancer survival
The anti-cancer drug AE-941, a shark cartilage derivative, did not improve overall survival in patients with inoperable stage III non-small cell lung cancer, according to a study published online May_26 in the Journal of the National Cancer Institute.

Thalidomide does not improve survival in lung cancer
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, revealed by researchers.

Down syndrome patients have a reduced risk for cancer
Most cancers are rare in people with Down syndrome, whose overall cancer mortality is below 10 percent of that in the general population.

3 Anti Angiogenic articles listed above.


Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.89